Paula Arana^1*, Bruno Paiva, PhD^2*, Noemi Puig, MD, PhD^3*, Teresa Cedena^4*, Lourdes Cordon^5*, Maria Belen Vidriales, MD, PhD^3*, Joaquin Martinez-López, MD.PhD^6*, Enrique M. Ocio, MD, PhD^7*, Miguel T Hernandez^8*, Ana Isabel Teruel, MD^9*, Mercedes Gironella^10*, M Asuncion Echeveste^11*, Laura Rosiñol, MD PhD^12*, Rafael Martinez, MD PhD^13*, Albert Oriol, MD PhD^14*, Joan Blade, MD PhD¹², Juan Jose Lahuerta^15*, Maria-Victoria Mateos¹⁶ and Jesus San Miguel, MD PhD^17*

¹Clinica Universidad de Navarra, Pamplona, Spain
²Department of Hematology and Immunology, Clinica Universidad de Navarra, Pamplona, Spain
³Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
⁴Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
⁵Hospital Universitario La Fe, Valencia, Spain
⁶Hematology, Hospital 12 de Octubre, Madrid, Spain
⁷University Hospital of Salamanca, Salamanca, Spain
⁸Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
⁹Hospital Clinico de Valencia, Valencia, Spain
¹⁰Hospital Universitari Vall dHebron, Barcelona, Spain
¹¹Hospital Universitario Donostia, San Sebastian, Spain
¹²Hospital Clinic de Barcelona, Barcelona, Spain
¹³Hospital Universitario San Carlos, Madrid, Spain
¹⁴Institut Català d’Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain
¹⁵Hospital 12 de Octubre, Madrid, Spain
¹⁶Hematology Department, University Hospital of Salamanca/IBSAL, Salamanca, Spain
¹⁷Centro de Investigación Médica Aplicada, University of Navarra, Clínica Universidad de Navarra, Pamplona, Spain

Jonathan J Keats, PhD¹, Gil Speyer^1*, Legendre Christophe^1*, Christofferson Austin^1*, Kristi Stephenson, BS^1*, Ahmet Kurdoglu^1*, Megan Russell^1*, Aldrich Jessica^1*, Cuyugan Lori^1*, Jonathan Adkins^1*, Jackie McDonald^1*, Adrienne Helland^1*, Alex Blanski^2*, Meghan Hodges^2*, Dan Rohrer^3*, Sundar Jagannath, MD⁴, David S Siegel, MD, PhD⁵, Ravi Vij, MD, MBA⁶, Gregory Orloff, MD⁷, Todd Zimmerman, MD⁸, Ruben Niesvizky, MD⁹, Darla Liles, MD¹⁰, Joseph W. Fay¹¹, Jeffrey L. Wolf, MD, PhD¹², Robert M. Rifkin¹³, Norma C Gutierrez^14*, The MMRF CoMMpass Network^15*, Jen Toups^15*, Mary Derome, MS^15*, Winnie Liang, PhD^1*, Seunchan Kim^1*, Daniel Auclair, PhD^15*, Pamela G. Kidd, MD¹⁶, Scott Jewell, PhD^2*, John David Carpten, PhD^1* and Sagar Lonial, MD^17,18

¹Translational Genomics Research Institute, Phoenix, AZ
²Van Andel Research Institute, Grand Rapids, MI
³Van Andel Research Institute, Phoenix, AZ
⁴Tisch Cancer Institute / Multiple Myeloma Program, Mount Sinai School of Medicine, New York, NY
⁵Hackensack University Medical Center, John Theurer Cancer Center, Hackensack, NJ
⁶Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO
⁷Fairfax Northern Virginia Hematology Oncology, Fairfax, VA
⁸University of Chicago Medical Center, Chicago, IL
⁹Center of Excellence for Lymphoma and Myeloma, Weill Cornell Medical College, New York, NY
¹⁰Department of Hematology/Oncology, Brody School of Medicine at East Carolina University, Greenville, NC
¹¹Baylor Univ. Medical Ctr., Dallas, TX
¹²University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
¹³Rocky Mountain Cancer Centers, Denver, CO
¹⁴Hematology, Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain
¹⁵Multiple Myeloma Research Foundation, Norwalk, CT
¹⁶Spectrum Health, Grand Rapids, MI
¹⁷Winship Cancer Institute, Emory University, Atlanta, GA
¹⁸Winship Cancer Institute of Emory University, Department of Hematology and Medical Oncology, Atlanta, GA

Elias Karl Mai, MD^1*, K. Martin Kortuem, MD^2*, Nur Hanafiah^1*, Santiago Barrio^3*, Laura Ann Bruins^3*, Maximilian Merz, MD^4*, Jing Xu^5*, Koenuel Pashayeva, MD^1*, Yuan-Xiao Zhu^2*, Chang-Xin Shi, PhD^2*, R. Alexander Stewart^2*, Patrick Jedlowski^2*, Mindaugas Andrulis, MD^5*, Anna Jauch, Prof.^6*, Jens Hillengass, MD⁷, Hartmut Goldschmidt, MD^1,8, P. Leif Bergsagel, MD, PhD², Esteban Braggio, PhD², A. Keith Stewart, MD^3,9 and Marc Steffen Raab, MD, PhD^1,10

¹Internal Medicine V, University Clinic Heidelberg, Heidelberg, Germany
²Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ
³Mayo Clinic, Scottsdale, AZ
⁴Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
⁵Institute of Pathology, University Clinic Heidelberg, Heidelberg, Germany
⁶Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany
⁷Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
⁸National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany
⁹Oncospire Inc., Rochester, MN
¹⁰Max Eder Group for Experimental Therapies for Hematologic Malignancies, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany

James E McDonald^1*, Marcus M Kessler^1*, Michael Gardner^2*, Amy Buros, PhD^3*, Sarah Waheed, MD^3*, James Ntambi^1*, Frits van Rhee, MD, PhD³, Maurizio Zangari, MD³, Christoph Heuck, MD³, Nathan Petty, MS^3*, Carolina Schinke, MD^3*, Sharmilan Thanendrarajan, MD³, Alan Mitchell^4*, Antje Hoering^4*, Bart Barlogie, MD, PhD³, Gareth J Morgan, MD, PhD³ and Faith E Davies, MD³

¹Department of Radiology, University of Arkansas for Medical Sciences, Little Rock, AR
²College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR
³Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR
⁴Cancer Research and Biostatistics, Seattle, WA

Bruno Paiva, PhD^1*, Maria Belen Vidriales, MD, PhD^2*, Noemi Puig, MD, PhD^2*, Teresa Cedena^3*, Lourdes Cordon^4*, Maria-Victoria Mateos⁵, Joaquin Martinez-López, MD.PhD^6*, Laura Rosiñol, MD PhD^7*, Alfonso Garcia de Coca, MD, PhD^8*, Natalia De Las Heras, MD^9*, Josefina Galende^10*, Jose Mariano Hernandez, MD^11*, Luis Palomera, MD PhD^12*, Javier De La Rubia^13*, Joan Blade, MD PhD⁷, Jesus San Miguel, MD PhD^14* and Juan Jose Lahuerta^15*

¹Department of Hematology and Immunology, Clinica Universidad de Navarra, Pamplona, Spain
²Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
³Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
⁴Hospital Universitario La Fe, Valencia, Spain
⁵Hematology Department, University Hospital of Salamanca/IBSAL, Salamanca, Spain
⁶Hematology, Hospital 12 de Octubre, Madrid, Spain
⁷Hospital Clinic de Barcelona, Barcelona, Spain
⁸Hospital Clínico Universitario de Valladolid, Valladolid, Spain
⁹Complejo Hospitalario de Leon, Leon, Spain
¹⁰Hospital Comarcal del Bierzo, Ponferrada, Spain
¹¹Hospital General de Segovia, Segovia, Spain
¹²Department of Hematology, Hospital Universitario Lozano Blesa, Zaragoza, Spain
¹³H.U.P. La Fe, Valencia, Spain
¹⁴Centro de Investigación Médica Aplicada, University of Navarra, Clínica Universidad de Navarra, Pamplona, Spain
¹⁵Hospital 12 de Octubre, Madrid, Spain

Mariateresa Fulciniti¹, Mehmet Kemal Samur, PhD^2*, Naim Ur Rashid, PhD^3*, Rajya Lakshmi Bandi, MS^4*, Manoj Bhasin, PhD^5*, Giovanni Parmigiani, PhD^2*, Kenneth C Anderson, MD⁶ and Nikhil C. Munshi, MD^6,7

¹The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
³Dana Farber, Boston
⁴Dana Farber Cancer Institute, Boston, MA
⁵BIDMC Genomics, Proteomics, Bioinformatics and Systems Biology Center, Boston, MA
⁶LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁷VA Medical Hospital, Boston, MA